195 related articles for article (PubMed ID: 37501527)
1. Financial toxicity of hidradenitis suppurativa: A single-center experience at an urban wound-care clinic.
Towfighi P; Huffman SS; Bovill JD; Shan HD; Haffner ZK; Kim EY; Slamin R; Benedict CD; Evans KK
J Dermatol; 2023 Oct; 50(10):1279-1286. PubMed ID: 37501527
[TBL] [Abstract][Full Text] [Related]
2. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.
Marvel J; Vlahiotis A; Sainski-Nguyen A; Willson T; Kimball A
BMJ Open; 2019 Sep; 9(9):e030579. PubMed ID: 31575575
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
4. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric Influences on Hidradenitis Suppurativa: A Call for Help.
Shan HD; Huffman SS; Bovill JD; Haffner ZK; Towfighi P; Benedict CD; Evans KK
Arch Plast Surg; 2024 May; 51(3):304-310. PubMed ID: 38737841
[No Abstract] [Full Text] [Related]
6. Factors affecting quality of life in patients with hidradenitis suppurativa.
Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
[TBL] [Abstract][Full Text] [Related]
7. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
8. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
[TBL] [Abstract][Full Text] [Related]
10. Assessing the psychological burden of patients with hidradenitis suppurativa.
Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
[TBL] [Abstract][Full Text] [Related]
11. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
12. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
[TBL] [Abstract][Full Text] [Related]
13. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
15. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
Hayama K; Fujita H; Hashimoto T; Terui T;
J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study.
Prens LM; Huizinga J; Janse IC; Horváth B
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1941-1946. PubMed ID: 31132177
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis Suppurativa From a Patient Perspective Including Symptoms and Self-Treatment.
Huang CM; Kirchhof MG
J Cutan Med Surg; 2021; 25(6):591-597. PubMed ID: 34137667
[TBL] [Abstract][Full Text] [Related]
18. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
Balcere A; Upeniece I; Snipe K; Jezupovs A
Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
[TBL] [Abstract][Full Text] [Related]
20. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
